MC
CELG

Moors & Cabot’s Celgene Corp CELG Stock Holding History

Moors & Cabot’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,833
Closed -$1.77M – 735
2019
Q3 		$1.77M Buy
17,833
+273
+2% +$25.9K 0.2% 127
2019
Q2 		$1.62M Buy
17,560
+2,010
+13% +$191K 0.21% 122
2019
Q1 		$1.46M Buy
15,550
+8,049
+107% +$704K 0.2% 124
2018
Q4 		$481K Sell
7,501
-1,615
-18% -$119K 0.08% 259
2018
Q3 		$813K Buy
9,116
+59
+0.7% +$5.21K 0.1% 223
2018
Q2 		$725K Buy
9,057
+1,665
+23% +$138K 0.1% 232
2018
Q1 		$659K Buy
7,392
+1,914
+35% +$184K 0.09% 265
2017
Q4 		$569K Buy
5,478
+1,285
+31% +$145K 0.08% 291
2017
Q3 		$611K Buy
4,193
+105
+3% +$14.3K 0.09% 271
2017
Q2 		$529K Buy
4,088
+487
+14% +$59.7K 0.09% 275
2017
Q1 		$447K Sell
3,601
-207
-5% -$24.8K 0.08% 295
2016
Q4 		$442K Buy
3,808
+501
+15% +$55.8K 0.07% 311
2016
Q3 		$344K Sell
3,307
-475
-13% -$51.4K 0.06% 343
2016
Q2 		$377K Sell
3,782
-2,595
-41% -$268K 0.07% 315
2016
Q1 		$638K Buy
6,377
+525
+9% +$54.1K 0.12% 217
2015
Q4 		$702K Sell
5,852
-1,330
-19% -$154K 0.13% 203
2015
Q3 		$780K Sell
7,182
-472
-6% -$58.6K 0.14% 179
2015
Q2 		$891K Buy
7,654
+584
+8% +$66.8K 0.14% 172
2015
Q1 		$822K Sell
7,070
-130
-2% -$15.5K 0.14% 179
2014
Q4 		$804K Buy
7,200
+860
+14% +$90.7K 0.14% 176
2014
Q3 		$598K Buy
6,340
+1,350
+27% +$122K 0.1% 222
2014
Q2 		$428K Buy
+4,990
New +$379K 0.07% 300

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Moors & Cabot's CELG Position: Q4 2019 in Review

Moors & Cabot sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,833 shares — an estimated $1.77M sold.

Moors & Cabot first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $1.77M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Moors & Cabot reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Moors & Cabot sold 17,833 Celgene Corp shares in Q4 2019, an estimated $1.77M.
  • Moors & Cabot first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Moors & Cabot's Celgene Corp position peaked at $1.77M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Moors & Cabot's 13F filing for Q4 2019, filed 28 Jan 2020.